Bronchial asthma and Chlamydia pneumoniae antibodies in children aged 4-8 years in Olomouc district

Frantisek Kopriva1, Jaroslava Szotkowská, Martin Zápalka

  • 1Department of Pediatrics, Palacky University, Olomouc, Czech Republic. Koprivaf@fnol.cz

Insights

Chlamydia pneumoniae infection is linked to asthma in children. This study found higher IgM and IgG antibody levels in atopic children with asthma, suggesting a connection between infection and pediatric asthma.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infectious Diseases

Background:

  • Previous research linked Chlamydia pneumoniae infection to asthma exacerbations in adults.
  • Limited data exists on C. pneumoniae's role in childhood asthma development.

Purpose of the Study:

  • To investigate the association between C. pneumoniae infection and asthma in atopic children.
  • To compare infection markers in children with chronic cough and asthma versus non-atopic controls.

Main Methods:

  • Serological detection of C. pneumoniae-specific IgM, IgG, and IgA antibodies.
  • Utilized Chlamydien-rELISA kits for antibody quantification.

Main Results:

  • Elevated IgM and IgG antibodies to C. pneumoniae were found in 44% of children with asthma.
  • 24% of atopic children with chronic cough showed positive antibodies.
  • 16% of non-atopic controls had detectable C. pneumoniae antibodies.

Conclusions:

  • Childhood asthma shows a significant association with elevated IgM and IgG antibodies to C. pneumoniae.
  • C. pneumoniae infection may play a role in the pathogenesis of pediatric asthma.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K